medigraphic.com
Instituto Nacional de Salud Pública

2018, Number 6

<< Back Next >>

salud publica mex 2018; 60 (6)

Prevalence and risk factors for oral human papillomavirus infection in Mexican HIV-infected men

Ablanedo-Terrazas Y, Romero-Mora K, Gómez-Palacio M, Alvarado-de la Barrera C, Ruiz-Cruz M, Hernández-Juan R, Reyes-Terán G

Language: English
References: 22
Page: 653-657
PDF size: 698.36 Kb.


ABSTRACT

Objective. To determine the prevalence and risk factors for oral high-risk human papillomavirus (HR-HPV) infection in human immunodeficiency virus (HIV)-infected men. Materials and methods. Consecutive male outpatients with HIV-infection were enrolled. Demographic and behavioral risk data were obtained. Anal swabs and oral rinses were tested for HR-HPV DNA. Oral, pharyngeal and video laryngoscopy examinations were performed for detection of lesions. Results. The prevalence of HR-HPV oral infection was 9.3% (subtypes other than HR HPV 16/18 predominated). The prevalence of anal HR-HPV infection was 75.7%. The risk factors for oral infection with HR-HPV were tonsillectomy (OR=13.12) and years from HIV diagnosis (OR=1.17). Conclusions. Tonsillectomy and years from HIV diagnosis were associated with oral HPV infection. No association was found between oral and anal HR-HPV infections. This is the first study reporting the prevalence and risk factors for oral HR-HPV infection in Mexican HIV-infected population.


REFERENCES

  1. Applebaum KM, Furniss CS, Zeka A, Posner MR, Smith JF, Bryan J, et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst. 2007;99:1801-10. https://doi. org/10.1093/jnci/djm233

  2. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-20. https://doi.org/10.1093/jnci/92.9.709

  3. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Kiskella P, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344:1125-31. https://doi. org/10.1056/NEJM200104123441503

  4. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human Papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294-301. https://doi.org/10.1200/ JCO.2011.36.4596

  5. Gayar OH, Ruterbusch JJ, Elshaikh M, Cote M, Ghanem T, Hall F, et al. Oropharyngeal carcinoma in young adults: An alarming national trend. Otolaryngol Head Neck Surg. 2014;150:594-601. https://doi. org/10.1177/0194599813519738

  6. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-27. https://doi. org/10.1056/NEJMoa021641

  7. Maxwell JH, Grandis JR, Ferris RL. HPV-Associated head and neck cancer: Unique features of epidemiology and clinical management. Annu Rev Med. 2016;67:91-101. https://doi.org/10.1146/annurevmed- 051914-021907

  8. Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis. 2004;189:686-98. https://doi. org/10.1086/381504

  9. Beachler DC, Abraham AG, Silverberg MJ, Beachler DC, Abraham AG, Silverberg MJ, et al. Incidence and risk factors of HPV-related and HPV-unrelated head and neck squamous cell carcinoma in HIV-infected individuals. Oral Oncol. 2014;50:1169-76. https://doi.org/10.1016/j.oraloncology. 2014.09.011

  10. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009;52:611-22. https://doi.org/10.1097/QAI.0b013e3181b327ca

  11. Read TR, Hocking JS, Vodstrcil LA, Tabrizi SN, McCullough MJ, Grulich AE, et al. Oral human papillomavirus in men having sex with men: risk-factors and sampling. Plos One. 2012;7(11):e49324. https://doi.org/10.1371/ journal.pone.0049324

  12. Beachler DC, Gypsyamber D, Sugar EA, Xiao W, Gillison ML. Natural History of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis. 2013;208:330-9. https://doi.org/10.1093/infdis/jit170

  13. Ong JJ, Read TR, Vodstrcil LA, Walker S, Chen M, Bradshaw CS, et al. Detection of oral Human Papillomavirus in HIV-positive men who have sex with men 3 years after baseline: A follow up cross-sectional study. Plos One. 2014;9(7):e102138. https://doi.org/10.1371/journal.pone.0102138.

  14. Hobbs CG, Groves E, Davenport V, Bailiy M, Williams NA, Birchall MA, et al. Tonsil T cell immunity to human papillomavirus in the absence of detectable virus in healthy adults. Laryngoscope. 2008;118:459-63. https:// doi.org/10.1097/MLG.0b013e31815aedb3

  15. Fakhry C, Rosenthal BT, Clark DP, Gillison ML. Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal “pap test equivalent” in high-risk populations. Cancer Prev Res. 2011;(4):1378-84. https://doi.org/10.1158/1940-6207.CAPR-11-0284

  16. Misiukiewicz K, Posner M. Role of prophylactic bilateral tonsillectomy as a cancer preventive strategy. Cancer Prev Res. 2015;8(5):580-2. https:// doi.org/10.1158/1940-6207.CAPR-15-0153

  17. Muller K, Kazimiroff J, Fatahzadeh M, Smith RV, Wiltz M, Polanco J, et al. Oral human papillomavirus infection and oral lesions in HIV-positive and HIV-negative dental patients. J Inf Dis. 2015;212(5):760-8. https://doi. org/10.1093/infdis/jiv080

  18. Chu FY, Lin YS, Cheng SH. Human papillomavirus infection in human immunodeficiency virus-positive Taiwanese women incarcerated for illicit drug usage. J Microbiol Immunol Infect. 2013;46(4):282-7. https://doi. org/10.1016/j.jmii.2012.06.009

  19. Read TR, Hocking JS, Vodstrcil LA, Tabrizi SN, McCullough MJ, Grulich AE, et al. Oral Human Papillomavirus in men having sex with men: Risk-factors and sampling. Plos One. 2012;7(11):e49324. https://doi. org/10.1371/journal.pone.0049324

  20. Kreimer AR, CliffordGM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467-75. https://doi. org/10.1158/1055-9965.EPI-04-0551

  21. Stephen JK, Chen KM, Shah V. Human papillomavirus outcomes in an access-to care laryngeal cancer cohort. Otolaryngol Head Neck Surg. 2012;146:730-8. https://doi.org/10.1177/0194599811434482

  22. Centers for Disease Control and Prevention. HPV-Associated Cancers and Precancers. Sexually Transmitted Diseases Treatment Guidelines. Centers for Disease Control and Prevention, 2016 [cited 2018, January 18]. Available from: http://www.cdc.gov/std/tg2015/hpv-cancer.htm




2020     |     www.medigraphic.com